8
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Effects of Permanent Eradication or Transient Clearance of Helicobacter pylori on Histology of Gastric Mucosa Using Omeprazole with or Without Antibiotics

, , , , &
Pages 105-110 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

H. J. O'Connor, C. A. O'Morain. (2001) Helicobacter pylori and Gastroesophageal Reflux Disease: To Treat or Not to Treat?. Scandinavian Journal of Gastroenterology 36:7, pages 677-682.
Read now

Articles from other publishers (17)

Javier P. Gisbert & Josep M. Piqué. (2005) Indicaciones y consecuencias de la erradicación de Helicobacter pylori en la enfermedad por reflujo gastroesofágico. Medicina Clínica 124:18, pages 697-709.
Crossref
A. Qasm, M. Buckley, H. O’Connor & C. O’Morain. 2003. Helicobactor pylori. Helicobactor pylori 503 512 .
M. Hojo, H. Miwa, T. Ohkusa, R. Ohkura, A. Kurosawa & N. Sato. (2002) Alteration of histological gastritis after cure of Helicobacter pylori infection . Alimentary Pharmacology & Therapeutics 16:11, pages 1923-1932.
Crossref
Peter P. Tagkalidis, Simon G. Royce, Finlay A. Macrae & Prithi S. Bhathal. (2002) Selective colonization by Helicobacter pylori of the deep gastric glands and intracellular canaliculi of parietal cells in the setting of chronic proton pump inhibitor use. European Journal of Gastroenterology & Hepatology 14:4, pages 453-456.
Crossref
Sayuri Yamamoto, Hiroshi Kaneko, Toshihiro Konagaya, Shozaburo Mori, Hiroshi Kotera, Toshihiko Hayakawa, Chikara Yamaguchi, Motoaki Uruma, Kazuo Kusugami & Terunori Mitsuma. (2001) Interactions Among Gastric Somatostatin, Interleukin-8 and Mucosal Inflammation in Helicobacter pylori-Positive Peptic Ulcer Patients. Helicobacter 6:2, pages 136-145.
Crossref
Javier P. Gisbert y & José María Pajares. (2001) ¿Está indicado erradicar la infección por Helicobacter pylori en los pacientes que requieren tratamiento a largo plazo con inhibidores de la bomba de protones?. Medicina Clínica 117:20, pages 793-797.
Crossref
S. Vigneri, R. Termini, V. Savarino & F. Pace. (2000) Is Helicobacter pylori status relevant in the management of GORD?. Alimentary Pharmacology & Therapeutics 14, pages 31-42.
Crossref
Premysl Bercik, Elena F. Verdu, David Armstrong, Jan-Peter Idstrom, Christer Cederberg, Michele Markert, Jean E. Crabtree, Manfred Stolte & Andre L. Blum. (2000) The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection. The American Journal of Gastroenterology 95:4, pages 947-955.
Crossref
Regina Lamberts. (2000) Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance. Microscopy Research and Technique 48:6, pages 357-366.
Crossref
M. F. Dixon, A. Lee & S. J. O. Veldhuyzen Van Zanten. 2000. Helicobacter pylori. Helicobacter pylori 327 338 .
Sander J.O. Veldhuyzen van Zanten, Michael F. Dixon & Adrian Lee. (1999) The gastric transitional zones: Neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterology 116:5, pages 1217-1229.
Crossref
Hala M.T El-Zimaity & David Y Graham. (1999) Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: Role of the sydney system. Human Pathology 30:1, pages 72-77.
Crossref
Inger Adamsson, Carl Erik Nord, Svante Sjöstedt, Bo Wikström & Rein Seensalu. (1998) The Value of Different Detection Methods of Helicobacter pylori During Treatment. Journal of Clinical Gastroenterology 27:2, pages 138-142.
Crossref
A. B. Price. 1998. Helicobacter pylori. Helicobacter pylori 209 214 .
N. Uemura, Y. Oomoto, T. Mukai, S. Okamoto, S. Yamaguchi, H. Mashiba, K. Taniyama, N. Sasaki, K. Sumii, K. Haruma & D Kajiyama. (1997) Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients. Alimentary Pharmacology and Therapeutics 11:4, pages 793-800.
Crossref
E. de Koster, C. L. Jonas, M. Ferhat, P. Denis, M. Buset & M. Deltenre. (1997) Helicobacter pylori doit-il être éradiqué avant de prescrire un traitement à long terme par un inhibiteur de pompe à protons pour une œsophagite par reflux?ShouldHelicobacter pylori be eradicated before starting a long term proton pump inhibitor treatment for reflux oesophagitis?. Acta Endoscopica 27:3, pages 201-211.
Crossref
G. N. J. Tytgat. 1996. Helicobacter pylori. Helicobacter pylori 304 311 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.